Effect of caprine herpes virus-1 (CpHV-1) on cell viability and chemosensitivity in breast cancer cells.
Iris Maria Forte(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Michelino De Laurentiis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Carmelina Antonella Iannuzzi(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Sara Damiano(Federico II University Hospital), Stefania Cocco(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandra Calabrese(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Claudia von Arx(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Sfera(University of Siena), Francesco Pagano(University of Salerno), Marianna Tomeo(Scuola Superiore Meridionale), Antonio Giordano(University of Siena)
Cited by 0
Related Papers
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
|The Lancet Oncology|2018|1k
Curcumin and Cancer
|Nutrients|2019|977
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413